Xeris Biopharma Holdings Inc (XERS)

01:37 AM

JPMorgan Chase & Co. Has $3.54 Million Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

01:37 AM

03:55 AM

Alliancebernstein L.P. Reduces Stock Position in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

03:55 AM

Apr 17, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Sees Large Growth in Short Interest - Defense World

Apr 17, 2025

Apr 15, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Acquired by Vanguard Group Inc. - Defense World

Apr 15, 2025

Apr 14, 2025

Raymond James Financial Inc. Makes New Investment in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Apr 14, 2025

Apr 13, 2025

Wellington Management Group LLP Sells 6,532 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Apr 13, 2025

Apr 12, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Purchased by Prudential Financial Inc. - Defense World

Apr 12, 2025

Mar 31, 2025

AIGH Capital Management LLC Purchases 389,192 Shares of Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - MarketBeat

Mar 31, 2025

Mar 31, 2025

Auto-Injectors Market Growth in Future Scope 2025-2032 | Sanofi - openPR

Mar 31, 2025

Mar 28, 2025

Xeris Pharmaceuticals Announces Board Changes with New Appointment - TipRanks

Mar 28, 2025

Mar 28, 2025

Xeris Biopharma reshuffles board, appoints new director By Investing.com - Investing.com South Africa

Mar 28, 2025

Mar 28, 2025

Xeris Announces Changes To Its Board Of Directors - MarketScreener

Mar 28, 2025

Mar 28, 2025

Xeris Biopharma reshuffles board, appoints new director - Investing.com

Mar 28, 2025

Mar 28, 2025

Xeris Announces Changes to Its Board of Directors - Business Wire

Mar 28, 2025

Mar 27, 2025

Is Xeris Biopharma Holdings (XERS) The Hot Biotech Stock Under $5? - Insider Monkey

Mar 27, 2025

Mar 25, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Shares Sold by Bank of New York Mellon Corp - Defense World

Mar 25, 2025

Mar 23, 2025

Don't Ignore The Insider Selling In Xeris Biopharma Holdings - simplywall.st

Mar 23, 2025

Mar 23, 2025

Connor Clark & Lunn Investment Management Ltd. Has $581,000 Stock Holdings in Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) - Defense World

Mar 23, 2025

Mar 23, 2025

Xeris Biopharma (NASDAQ:XERS) Stock Price Up 4.9% – Here’s Why - Defense World

Mar 23, 2025

Mar 22, 2025

Xeris Biopharma chief legal officer Beth Hecht sells $217,244 in stock - Investing.com India

Mar 22, 2025

Mar 21, 2025

Xeris Biopharma chief legal officer Beth Hecht sells $217,244 in stock By Investing.com - Investing.com South Africa

Mar 21, 2025

Mar 21, 2025

Xeris Pharmaceuticals stock hits 52-week high at $5.54 - Investing.com

Mar 21, 2025

Mar 21, 2025

Xeris Pharmaceuticals stock hits 52-week high at $5.54 By Investing.com - Investing.com South Africa

Mar 21, 2025

Mar 20, 2025

Strength Seen in Xeris Biopharma (XERS): Can Its 5.6% Jump Turn into More Strength? - Yahoo Finance

Mar 20, 2025

Mar 20, 2025

Xeris Biopharma (NASDAQ:XERS) Reaches New 52-Week High – Time to Buy? - Defense World

Mar 20, 2025

Mar 19, 2025

Xeris Biopharma Holdings (XERS): Among the Best Stocks to Invest in for a Stock Market Game - Insider Monkey

Mar 19, 2025

Mar 19, 2025

Xeris enters a whole new market for one of its main pharma offerings - Crain's Chicago Business

Mar 19, 2025

Mar 19, 2025

Is XERS Stock a Good Buy in 2025? Key Insights for Investors - Stocks Telegraph

Mar 19, 2025

Mar 18, 2025

12 Best Stocks to Invest in for a Stock Market Game - Insider Monkey

Mar 18, 2025

Mar 18, 2025

Xeris Biopharma gets FDA nod for Gvoke VialDx, teams with American Regent - Investing.com Australia

Mar 18, 2025

Mar 17, 2025

Xeris Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke VialDx™ (glucagon) for Use as a Diagnostic Aid - BioSpace

Mar 17, 2025

Mar 17, 2025

Xeris Biopharma Says US FDA Approves Gvoke VialDx for Diagnostic Use -March 17, 2025 at 08:33 am EDT - Marketscreener.com

Mar 17, 2025

Mar 17, 2025

Xeris Biopharma gets FDA nod for Gvoke VialDx, teams with American Regent By Investing.com - Investing.com South Africa

Mar 17, 2025

Mar 16, 2025

Xeris Biopharma: Low Risk, Low Excitement Solid Revenue Generator (NASDAQ:XERS) - Seeking Alpha

Mar 16, 2025

Mar 16, 2025

Investors Appear Satisfied With Xeris Biopharma Holdings, Inc.'s (NASDAQ:XERS) Prospects As Shares Rocket 34% - Simply Wall St

Mar 16, 2025

Mar 16, 2025

Xeris BiopharmaPossibly the best Pharma Stock - MSN

Mar 16, 2025

Mar 13, 2025

Analysts Set Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Target Price at $5.92 - Defense World

Mar 13, 2025

Mar 11, 2025

Will Xeris Biopharma's Financial Transformation Reach New Heights In 2025? - RTTNews

Mar 11, 2025

Mar 11, 2025

Xeris Biopharma (XERS) Expects to Ride the Wave of 30% Revenue Growth in 2025 - Markets Insider

Mar 11, 2025

Mar 10, 2025

What Are Expectations For Xeris Biopharma Holdings Inc (NASDAQ: XERS) In The Short Term? - Stocks Register

Mar 10, 2025

Mar 10, 2025

Xeris Biopharma Holdings, Inc. (NASDAQ:XERS) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 10, 2025

Mar 10, 2025

Analysts Issue Forecasts for Xeris Biopharma Q1 Earnings - Defense World

Mar 10, 2025